Werd, the US infant shortage relates to special formula which is mostly the hypoallergenic type. A2 and Bubs don’t make these special types of formula. Therefore a waste of time, resources and funds to try and enter this market. Sure in the short term it’s good publicity if they can, but won’t convert into $$$.Too much hype, just my opinion….
US FDA Eases Baby-Formula Import Rules to Boost US Supplies, page-86
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.28 |
Change
0.090(1.73%) |
Mkt cap ! $3.822B | |||
| Open | High | Low | Value | Volume |
| $5.23 | $5.29 | $5.14 | $18.87M | 3.614M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12652 | $5.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.29 | 3513 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |